International Symposium on Pharmacy and Drug Discovery (ISPDD - 26)

This track will explore the latest innovations in drug discovery technologies, including high-throughput screening and computational drug design. Participants will discuss how these advancements can enhance the efficiency and efficacy of pharmaceutical research.

This session focuses on the evolving landscape of pharmacology and its implications for therapeutic innovations. Researchers will present novel pharmacological approaches that aim to improve patient outcomes and safety.

This track will address the current challenges faced in medicinal chemistry, including drug resistance and formulation issues. Experts will share their insights on emerging strategies and technologies that can overcome these obstacles.

This session emphasizes the role of clinical pharmacy in enhancing patient-centered care. Discussions will highlight best practices and innovative approaches to optimize medication management in diverse healthcare settings.

This track will delve into the critical aspects of formulation science and its impact on drug development. Participants will examine case studies that illustrate the importance of formulation strategies in achieving therapeutic efficacy.

This session aims to bridge the gap between pharmaceutical sciences research and clinical practice. Presentations will focus on translational research efforts that facilitate the application of scientific findings to improve patient care.

This track will cover essential topics related to drug safety and risk management in the pharmaceutical industry. Experts will discuss regulatory frameworks, post-marketing surveillance, and strategies to mitigate adverse drug reactions.

This session will highlight innovative practices in pharmacy that enhance service delivery and patient engagement. Participants will share successful models and interventions that have improved pharmacy practice outcomes.

This track will explore the role of pharmacogenomics in the development of personalized medicine. Discussions will focus on how genetic variations influence drug response and the implications for tailored therapeutic strategies.

This session will examine emerging trends and future directions in pharmaceutical research. Researchers will present cutting-edge studies that address current challenges and opportunities in drug discovery and development.

This track will focus on the importance of collaboration among academia, industry, and regulatory bodies in drug development. Participants will discuss successful partnerships that have accelerated the drug discovery process.